Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
91.95 SEK | +3.08% |
|
-0.87% | -14.70% |
06-14 | Enveda Therapeutics, Inc. announced that it has received $55 million in funding from a group of investors | CI |
06-05 | Kinnevik AB Approves Extra Distribution | CI |
Sales 2024 * | 695M 66.03M 90.18M | Sales 2025 * | 1.57B 149M 203M | Capitalization | 24.87B 2.36B 3.23B |
---|---|---|---|---|---|
Net income 2024 * | 622M 59.11M 80.72M | Net income 2025 * | 1.47B 140M 191M | EV / Sales 2024 * | 39.6 x |
Net Debt 2024 * | 2.68B 255M 348M | Net Debt 2025 * | 6.03B 573M 783M | EV / Sales 2025 * | 19.7 x |
P/E ratio 2024 * |
39.7
x | P/E ratio 2025 * |
16.8
x | Employees | 46 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.04% |
Latest transcript on Kinnevik AB
1 day | +3.08% | ||
1 week | -0.87% | ||
Current month | -25.57% | ||
1 month | -27.47% | ||
3 months | -23.06% | ||
6 months | -15.49% | ||
Current year | -14.70% |
![Extreme 89.2](/images/extremecours_fleche.png)
![Extreme 89.2](/images/extremecours_fleche.png)
![Extreme 89.2](/images/extremecours_fleche.png)
![Extreme 89.2](/images/extremecours_fleche.png)
![Extreme 89.2](/images/extremecours_fleche.png)
![Extreme 89.2](/images/extremecours_fleche.png)
![Extreme 89.2](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 17-12-31 | |
Samuel Sjöström
DFI | Director of Finance/CFO | 37 | 12-12-31 |
Chief Investment Officer | 53 | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Anderson
CHM | Chairman | 65 | 21-04-28 |
Director/Board Member | 65 | 18-04-30 | |
Olof Harald Mix
BRD | Director/Board Member | 64 | 21-04-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-26 | 91.1 | +2.13% | 1 508 |
24-06-25 | 89.2 | -5.11% | 18,927 |
24-06-24 | 94 | +0.64% | 5,529 |
24-06-20 | 93.4 | +1.63% | 12,396 |
24-06-19 | 91.9 | -5.45% | 8,745 |
Delayed Quote Nasdaq Stockholm, June 26, 2024 at 03:34 am
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+24.62% | 83.29B | |
+10.48% | 17.44B | |
+53.81% | 16.82B | |
+9.46% | 14.71B | |
-3.68% | 12.37B | |
+11.11% | 11.5B | |
-0.18% | 10.97B | |
+28.43% | 10.06B | |
-5.01% | 9.33B |
- Stock Market
- Equities
- KINV B Stock
- KINV A Stock